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Beta-arrestin 2 (ARRB2) is expressed in the brain and it is
involved in μ-opiate and dopamine D2 receptor signaling
(Lefkowitz and Shenoy, 2005). It has recently been shown
that the ARRB2 genotype may contribute to the inter-
individual variability in the response to methadone mainten-
ance treatment (Oneda et al., 2010). In addition, ARRB2
modulates the acute response to ethanol and mediates its
rewarding effects in mice (Bjork et al., 2008). To investigate
the signiﬁcance of this ﬁnding in human, genomic DNA was
collected from 45 males and 28 females of Caucasian origin,
18 years old or older, who met the criteria for the diagnosis of
alcohol dependence (Diagnostic and Statistical Manual
of Mental Disorders, DSM-IV, American Psychiatric
Association, 1994). Potential study subjects were excluded if
they had a history of psychotic or bipolar disorders. The DNA
from 103 males and 108 females of Caucasian origin without
any lifetime history of psychotic or mood disorders, alcohol
or heroin dependence [assessed using the semi-structured
Diagnostic Interview for Genetic studies (Nurnberger et al.,
1994) or the Schedules for Assessment in Neuropsychiatry
(Wing et al., 1990)] was used as non-alcoholic control group.
The ethics committees of the corresponding centers
(Lausanne, Geneva) approved the study and written informed
consent was obtained from all participants.
Four Single Nucleotide Polymorphisms (SNPs)
(rs34230287 in the promoter, rs3786047 in intron 1,
rs1045280 in exon 11 and rs2036657 in the 30UTR) were
selected on the basis of high heterozygosity and uniform
coverage of the gene. Genotyping was performed using com-
mercially available TaqMan probe (Applied Biosystems,
Rotkreuz, Switzerland) with ABI PRISM 7000 Sequence
Detection System as previously described (Oneda et al.,
2010). χ2 test was used to compare allele and genotype fre-
quencies across the alcoholic and non-alcoholic subjects.
Logistic regression was used for the analysis adjusted for sex
and age. Haplotype block structure was determined using the
Haploview program.
Linkage disequilibrium among the four SNPs was high
(D0 > 0.94). All the SNPs were in Hardy–Weinberg equili-
brium (P > 0.2). In the alcoholic group, the observed allele
frequencies were 32% (95% CI = 24.1–39.7%) for
rs1045280, rs3786047, rs2036657 and 27% (95% CI =
20.4–35.4%) for rs34230287. In the control group, the
observed allele frequencies were 30% (95% CI = 26.4–
35.5%) for 8622C, rs3786047, rs2036657 and 22% (95%
CI = 17.7–25.8%) for rs34230287, respectively. For all the
SNPs analyzed, the allele and genotype frequencies were not
signiﬁcantly different between the alcoholic patients and the
control group, nor in the multivariate analysis following
adjustment for sex and age (P > 4). Finally, the four marker
haplotypes were not signiﬁcantly associated with alcohol
dependence (P > 0.1) either.
On the basis of results obtained in animals (Bjork et al.,
2008), ARRB2 gene appeared to be a potential candidate for
association studies with alcoholism. No association could be
demonstrated in the present study, which is, to our knowl-
edge, the ﬁrst report on this matter in human. Our data are in
line with previously published results using the Indian
ethanol preferring and non-preferring rats (Saba et al., 2006).
In addition, the ARRB2 gene does not reside in any of the
quantitative trait loci for ethanol preference that have been
identiﬁed in rodents so far (Saba et al., 2006). In a recent
study with 272 opioid-dependent patients and 217 control
subjects without any lifetime history of psychotic or mood
disorders, alcohol or heroin dependence, ARRB2 was not
found to be a vulnerability gene for opioid dependence
either (Oneda et al., 2010). Further studies are needed to
conﬁrm the lack of association between ARRB2 and alcohol-
ism dependence in other cohorts but based on the present
study, a strong association appears unlikely.
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